Unless Congress closes a loophole in the orphan drug law, new products containing the opioid addiction treatment buprenorphine could be blocked from the market until 2024.
Gavin draws on more than 25 years of experience in communicating about science, medicine and health policy. She focuses mainly on the research of the 640 health services wonks who belong to the U-M Institute for Healthcare Policy and Innovation, who work to understand and improve the safety, quality, equity and affordability of health care. As part of the Michigan Medicine communication team, she has lead responsibility for primary care and mental health topics.
Healthy Michigan Plan enrollees experienced a six-point increase in employment or student status in one year, while employment for all Michiganders stayed the same.
Twenty years ago, research on the health impacts of being uninsured helped build the momentum that led to the Affordable Care Act. But new research shows that accessing care is still unaffordable for many, even after the ACA.
Surge in robotic surgery in 2010s outpaces the evidence for its effects on patients and costs, researchers warn.
Overdose Rates Are Higher, but Opioid Addiction Care Is Harder to Find in Medicaid Work Requirement States
Getting addiction diagnosis or treatment could make the difference between keeping and losing health care coverage for people with substance use disorder in 17 states.